INTC Research Update — June 20, 2026
Updated Thesis
Intel Corporation is a leading semiconductor company operating primarily in the technology sector with a focus on semiconductors. The business quality is currently challenged due to negative earnings growth of 354.1% in the most recent quarter and negative profitability metrics including a net margin of -5.9% and operating margin of -9.4%. Despite a sizable market cap of $1678.9 billion and revenue growth of 7.2% in the most recent quarter, the stock is trading 5.2% above its fair value estimate of $126.97 at a price of $133.99, indicating overvaluation.
The investment grade as of this refresh is D — solid business quality. Low-tier business, very expensive valuation with 5.2% downside to $126.97 fair value
Key Metrics at a Glance
- Revenue growth: +7.2% year over year
- Net margin: -5.9%
- Forward P/E: -216.1x
- Fair value upside: -5.2% to our estimate of $127
Current price: $133.99
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Intel Corporation remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full INTC research →](/stocks/INTC)